Table of Content

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Growth in the Biopharmaceutical Market
4.2.1.1. Rising Demand for Biopharmaceuticals
4.2.1.2. Strong R&D Pipeline for Biopharmaceuticals
4.2.1.3. Government Initiatives to Promote Biosimilars
4.2.1.4. Capacity Expansions of Biopharmaceutical Plants
4.2.2. Increasing Prevalence of Chronic Diseases
4.2.3. Growing Demand for Monoclonal Antibodies
4.2.4. Increase in Research Funding
4.2.5. Rising adoption of Single-use technologies
4.3. Restraints
4.3.1. Limitations in the Production of High-Density Cell Cultures
4.3.2. High Cost of Cell Culture Studies
4.4. Opportunities
4.4.1. Growing Adoption of 3D Cell Culture
4.4.2. Personalized Medicine to offer New Growth Potential
4.5. Challenges
4.5.1. Disposal of Plastic Waste Generated from Single-Use Technologies
4.5.2. Cell Line Misidentification and Cross Contamination
4.5.3. Reproducibility of Results
4.6. The Impact of COVID-19 on the Cell Culture Market

5. Global Cell Culture Market, by Product
5.1. Introduction
5.2. Consumables
5.2.1. Media
5.2.1.1. Form
5.2.1.1.1. Dry Form
5.2.1.1.2. Liquid Form
5.2.1.2. Type
5.2.1.2.1. Off-the-Shelf Media
5.2.1.2.2. Custom Media
5.2.1.3. Source
5.2.1.3.1. Serum-free Media
5.2.1.3.2. Chemically Defined Media
5.2.1.3.3. Classical Media
5.2.1.3.4. Xeno-free/Animal Component Free
5.2.2. Reagents
5.2.2.1. Growth Factors and Cytokines
5.2.2.2. Cryoprotective Reagents
5.2.2.3. Antibiotics/Antimycotics
5.2.2.4. Cell Dissociation Reagents
5.2.2.5. Buffers
5.2.2.6. Balanced Salt Solutions
5.2.2.7. Attachment and Matrix Factors
5.2.2.8. Other Cell Culture Reagents
5.2.3. Cells and Cell Lines
5.2.4. Sera
5.2.4.1. Fetal Bovine Serum
5.2.4.2. Other Sera Types
5.2.5. Cell Culture Vessels
5.2.5.1. Cell Culture Dishes
5.2.5.2. Cell Culture Plates
5.2.5.2.1. 6 to 24-well Plates
5.2.5.2.2. 48-well Plates
5.2.5.2.3. 96 to 384-well Plates
5.2.5.3. Cell Culture Flasks
5.2.5.4. Roller Bottles
5.2.5.5. Other Cell Culture Vessels
5.3. Equipment
5.3.1. Bioreactors
5.3.2. Biosafety Cabinets
5.3.3. Incubators
5.3.4. Cryopreservation Containers
5.3.5. Refrigerators and Freezers
5.3.6. Sterilizers
5.3.7. Microscopes
5.3.8. Centrifuges
5.3.9. Cell Counters
5.3.10. Water Baths
5.3.11. Other Equipment

6. Global Cell Culture Market, by Application
6.1. Introduction
6.2. Bioproduction
6.2.1. Monoclonal Antibody Production
6.2.2. Therapeutic Protein Production
6.2.3. Vaccine Production
6.2.4. Cell and Gene therapy
6.3. Drug Screening & Development
6.4. Cancer Research
6.5. Stem Cell Research
6.6. Other Applications

7. Global Cell Culture Market, by End User
7.1. Introduction
7.2. Pharmaceutical & Biotechnology Companies
7.3. Academic & Research Institutes
7.4. Other End Users

8. Cell Culture Market, by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa

9. Competitive Landscape
9.1. Introduction
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.3.1. Competitive Benchmarking, by Product
9.4. Market Share Analysis (2021)
9.4.1. Thermo Fisher Scientific Inc. (U.S.)
9.4.2. Cytiva (U.S.)
9.4.3. Merck KGaA (Germany)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
10.1. HiMedia Laboratories
10.2. Merck KGaA
10.3. Cytiva (Danaher Corporation)
10.4. Agilent Technologies, Inc.
10.5. Thermo Fisher Scientific Inc.
10.6. FUJIFILM Holdings Corporation
10.7. Lonza Group Ltd.
10.8. Corning Incorporated
10.9. Becton, Dickinson and Company
10.10. Sartorius AG
10.11. Miltenyi Biotec B.V. & Co. KG
10.12. Bio-Rad Laboratories, Inc.
10.13. Eppendorf SE
10.14. Avantor, Inc.
10.15. Greiner Bio-One GmbH
10.16. Getinge AB
11. Appendix
11.1. Questionnaire
11.2. Available Customization



List of Figures

List of Figures

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Cell Culture Market Size, by Product, 2022 Vs. 2029 (USD Million)
Figure 8 Global Cell Culture Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 9 Global Cell Culture Market Size, by End User, 2022 Vs. 2029 (USD Million)
Figure 10 Global Cell Culture Market Size, by Geography, 2022 Vs. 2029 (USD Million)
Figure 11 Market Dynamics
Figure 12 Population Aged 65 Years or Over, by Region, 2020 Vs. 2030 (In Million)
Figure 13 R&D Spending by Pharma Companies: 2018-2021
Figure 14 Global Cell Culture Market Size, by Product, 2022 Vs. 2029 (USD Million)
Figure 15 Global Cell Culture Market Size, by Application, 2022 Vs. 2029 (USD Million) 2
Figure 16 Number of CDER-Approved Novel Drugs: 2019–2021
Figure 17 Cancer Incidence Cases 2020-2030
Figure 18 Global Cell Culture Market Size, by End User, 2022 Vs. 2029 (USD Million)
Figure 19 Biopharmaceutical R&D Spending (USD Billion)
Figure 20 Global Cell Culture Market Size, by Region, 2022 Vs. 2029 (USD Million)
Figure 21 North America: Cell Culture Market Snapshot
Figure 22 U.S.: Number of New Cancer Cases, 2010–2030 (In Thousand)
Figure 23 Europe: Cell Culture Market Snapshot
Figure 24 Asia-Pacific: Cell Culture Market Snapshot
Figure 25 Key Growth Strategies Adopted by Leading Players (2019–2022)
Figure 26 Cell Culture Market: Competitive Benchmarking
Figure 27 Market Share Analysis: Cell Culture Industry (2021)
Figure 28 Merck KGaA: Financial Overview (2021)
Figure 29 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 30 Danaher Corporation: Financial Overview (2021)
Figure 31 Lonza Group Ltd.: Financial Overview (2021)
Figure 32 Corning Incorporated: Financial Overview (2021)
Figure 33 Becton, Dickinson and Company: Financial Overview (2021)
Figure 34 Sartorius AG: Financial Overview (2021)
Figure 35 Eppendorf SE: Financial Overview (2020)
Figure 36 FUJIFILM Holdings Corporation: Financial Overview (2020)
Figure 37 Agilent Technologies, Inc.: Financial Overview (2021)
Figure 38 Getinge AB: Financial Overview (2021)
Figure 39 Avantor, Inc.: Financial Overview (2021)
Figure 40 Bio-Rad Laboratories, Inc.: Financial Overview (2021)
Figure 41 Greiner AG: Financial Overview (2021)